T
Thereasa A. Rich
Researcher at University of Texas MD Anderson Cancer Center
Publications - 61
Citations - 3263
Thereasa A. Rich is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Pheochromocytoma & Paraganglioma. The author has an hindex of 24, co-authored 56 publications receiving 2993 citations. Previous affiliations of Thereasa A. Rich include Washington University in St. Louis & University of Texas Health Science Center at Houston.
Papers
More filters
Journal ArticleDOI
Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas.
Francis R. Spitz,James L. Abbruzzese,Jeffrey E. Lee,Peter W.T. Pisters,Andrew M. Lowy,Claudia J. Fenoglio,Karen R. Cleary,Nora A. Janjan,Mary S. Goswitz,Thereasa A. Rich,Douglas B. Evans +10 more
TL;DR: Delivery of preoperative and postoperative chemoradiation in patients who underwent potentially curative pancreaticoduodenectomy for adenocarcinoma of the pancreatic head resulted in similar treatment toxicity, patterns of tumor recurrence, and survival.
Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas
Francis R. Spitz,James L. Abbruzzese,Jeffrey E. Lee,Peter W.T. Pisters,Andrew M. Lowy,Claudia J. Fenoglio,Karen R. Cleary,Nora A. Janjan,Mary S. Goswitz,Thereasa A. Rich,Douglas B. Evans +10 more
TL;DR: In this article, the effects of preoperative versus postoperative fluorouracil (5-FU)-based chemotherapy and irradiation on treatment toxicity, duration of treatment, tumor recurrence, and survival were compared in patients who underwent potentially curative therapy for adenocarcinoma of the pancreatic head during a 5-year period.
Journal ArticleDOI
Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: Primary tumor size and primary tumor location as prognostic indicators
Montserrat Ayala-Ramirez,Lei Feng,Marcella M. Johnson,Shamim Ejaz,Mouhammed Amir Habra,Thereasa A. Rich,Naifa L. Busaidy,Gilbert J. Cote,Nancy D. Perrier,Alexandria T. Phan,Shreyaskumar Patel,Steven G. Waguespack,Camilo Jimenez +12 more
TL;DR: The size and location of the primary tumor were significant clinical risk factors for metastasis and decreased overall survival duration and delineate the follow-up and treatment for these tumors.
Journal ArticleDOI
A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma.
Steven G. Waguespack,Thereasa A. Rich,Elizabeth G. Grubbs,Anita K. Ying,Nancy D. Perrier,Montserrat Ayala-Ramirez,Camilo Jimenez +6 more
TL;DR: Although PHEO/PGL are rarely diagnosed during childhood, the pediatric provider should be able to recognize and screen for such tumors, particularly in the context of a known genetic predisposition.
Journal ArticleDOI
Current and Future Treatments for Malignant Pheochromocytoma and Sympathetic Paraganglioma
Camilo Jimenez,Eric M. Rohren,Mouhammed Amir Habra,Thereasa A. Rich,Paola Jimenez,Montserrat Ayala-Ramirez,Eric Baudin +6 more
TL;DR: An updated review of the clinical and genetic predictors of malignant disease, radiographic diagnosis, and information from the most relevant studies of systemic therapies, as well as proposed treatment guidelines for patients with metastatic or potentially malignant PHs and SPGs are provided.